Adverse events38

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 38

Type	Event	Organ system	Group	Affected	At risk
other	Abdominal pain	Gastrointestinal disorders	3 mg/kg of Lirentelimab (AK002)	5	91
other	Abdominal pain	Gastrointestinal disorders	Placebo	5	89
other	Nausea	Gastrointestinal disorders	3 mg/kg of Lirentelimab (AK002)	2	91
other	Nausea	Gastrointestinal disorders	Placebo	5	89
other	Vomiting	Gastrointestinal disorders	3 mg/kg of Lirentelimab (AK002)	3	91
other	Vomiting	Gastrointestinal disorders	Placebo	5	89
other	Fatigue	General disorders	3 mg/kg of Lirentelimab (AK002)	5	91
other	Fatigue	General disorders	Placebo	1	89
other	Corona virus infection	Infections and infestations	3 mg/kg of Lirentelimab (AK002)	4	91
other	Corona virus infection	Infections and infestations	Placebo	6	89
other	Urinary tract infection	Infections and infestations	3 mg/kg of Lirentelimab (AK002)	3	91
other	Urinary tract infection	Infections and infestations	Placebo	5	89
other	Infusion related reaction	Injury, poisoning and procedural complications	3 mg/kg of Lirentelimab (AK002)	31	91
other	Infusion related reaction	Injury, poisoning and procedural complications	Placebo	12	89
other	Coronavirus test positive	Investigations	3 mg/kg of Lirentelimab (AK002)	3	91
other	Coronavirus test positive	Investigations	Placebo	6	89
serious	Anaemia	Blood and lymphatic system disorders	3 mg/kg of Lirentelimab (AK002)	0	91
serious	Anaemia	Blood and lymphatic system disorders	Placebo	1	89
serious	Biliary dyskinesia	Hepatobiliary disorders	3 mg/kg of Lirentelimab (AK002)	0	91
serious	Biliary dyskinesia	Hepatobiliary disorders	Placebo	1	89

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04322604/events